Currently holds a position at Biohaven Pharmaceutical Holding Company Ltd
Position | Company | Period |
---|---|---|
Independent Director | Biohaven Pharmaceutical Holding Company Ltd | Aug. 2, 2017 - |
Chief Executive Officer, Director | ContraFect Corp | April 1, 2014 - March 21, 2016 |
Chief Executive Officer | ContraFect Corp | Nov. 1, 2013 - April 1, 2014 |
Chief Financial Officer, Executive Vice President | ContraFect Corp | July 1, 2012 - Nov. 1, 2013 |
President, CEO, Board Member | Five Prime Therapeutics Inc | None - |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2022-10-26 | 2022-10-25 |
Biohaven Ltd
(BHVN)
|
B Purchase |
9,523
+59.0%
10.5099,992 USD |
9,523 +59.0% | 10.50 | 99,992 USD | |
2021-12-22 | 2021-12-20 | PS Planned sale |
12,000
-100.0%
125.001,500,000 USD |
12,000 -100.0% | 125.00 | 1,500,000 USD | ||
2019-02-25 | 2019-02-21 | PS Planned sale |
12,000
-100.0%
43.56522,720 USD |
12,000 -100.0% | 43.56 | 522,720 USD | ||
2004-05-05 | 2004-05-03 |
Lexicon Pharmaceuticals Inc
(LXRX)
|
S Sale |
393
-0.6%
7.252,849 USD |
393 -0.6% | 7.25 | 2,849 USD | |
2004-05-05 | 2004-05-03 |
Lexicon Pharmaceuticals Inc
(LXRX)
|
S Sale |
1,503
-2.3%
7.2410,882 USD |
1,503 -2.3% | 7.24 | 10,882 USD | |
2004-05-05 | 2004-05-03 |
Lexicon Pharmaceuticals Inc
(LXRX)
|
S Sale |
900
-1.4%
7.226,498 USD |
900 -1.4% | 7.22 | 6,498 USD | |
2004-05-05 | 2004-05-03 |
Lexicon Pharmaceuticals Inc
(LXRX)
|
S Sale |
104
-0.2%
7.21750 USD |
104 -0.2% | 7.21 | 750 USD | |
2004-05-05 | 2004-05-03 |
Lexicon Pharmaceuticals Inc
(LXRX)
|
S Sale |
3,483
-5.1%
7.2025,078 USD |
3,483 -5.1% | 7.20 | 25,078 USD | |
2004-05-05 | 2004-05-03 |
Lexicon Pharmaceuticals Inc
(LXRX)
|
S Sale |
500
-0.7%
7.193,595 USD |
500 -0.7% | 7.19 | 3,595 USD | |
2004-05-05 | 2004-05-03 |
Lexicon Pharmaceuticals Inc
(LXRX)
|
S Sale |
1,200
-1.7%
7.168,592 USD |
1,200 -1.7% | 7.16 | 8,592 USD | |
2004-05-05 | 2004-05-03 |
Lexicon Pharmaceuticals Inc
(LXRX)
|
S Sale |
2,817
-3.8%
7.1520,142 USD |
2,817 -3.8% | 7.15 | 20,142 USD | |
2004-05-05 | 2004-05-03 |
Lexicon Pharmaceuticals Inc
(LXRX)
|
S Sale |
3,100
-4.1%
7.1422,134 USD |
3,100 -4.1% | 7.14 | 22,134 USD | |
2004-05-05 | 2004-05-03 |
Lexicon Pharmaceuticals Inc
(LXRX)
|
S Sale |
3,000
-3.8%
7.1321,390 USD |
3,000 -3.8% | 7.13 | 21,390 USD | |
2004-05-05 | 2004-05-03 |
Lexicon Pharmaceuticals Inc
(LXRX)
|
S Sale |
2,497
-3.0%
7.1217,779 USD |
2,497 -3.0% | 7.12 | 17,779 USD | |
2004-05-05 | 2004-05-03 |
Lexicon Pharmaceuticals Inc
(LXRX)
|
S Sale |
4,523
-5.2%
7.1132,159 USD |
4,523 -5.2% | 7.11 | 32,159 USD | |
2004-05-05 | 2004-05-03 |
Lexicon Pharmaceuticals Inc
(LXRX)
|
S Sale |
7,820
-8.3%
7.1055,522 USD |
7,820 -8.3% | 7.10 | 55,522 USD | |
2004-05-05 | 2004-05-03 |
Lexicon Pharmaceuticals Inc
(LXRX)
|
S Sale |
800
-0.8%
7.095,672 USD |
800 -0.8% | 7.09 | 5,672 USD | |
2004-05-05 | 2004-05-03 |
Lexicon Pharmaceuticals Inc
(LXRX)
|
S Sale |
200
-0.2%
7.071,414 USD |
200 -0.2% | 7.07 | 1,414 USD | |
2004-05-05 | 2004-05-03 |
Lexicon Pharmaceuticals Inc
(LXRX)
|
S Sale |
3,160
-3.2%
7.0622,310 USD |
3,160 -3.2% | 7.06 | 22,310 USD |